首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1846012

全球藥用明膠市場規模（按類型、應用、來源、最終用戶、區域範圍和預測）

Global Pharmaceutical Gelatin Market Size By Type, By Application, By Source, By End-User, By Geographic Scope And Forecast

出版日期: 2025年09月22日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

藥用明膠市場規模及預測

預計 2024 年藥用明膠市場價值將達到 12.4 億美元，2031 年將達到 17.9 億美元，2024 年至 2031 年的複合年成長率為 5.20%。

藥用明膠來自動物皮膚、白色結締組織和骨骼中的膠原蛋白部分水解，具有分子量大、熱可逆性、生物相容性和水溶性好等特點，是製藥工業中重要的輔料。

明膠主要用於製造硬膠囊和軟膠囊，作為屏障保護魚油等敏感成分免受氧氣、光、污染和微生物生長的影響。

它的用途包括片劑粘合劑、疫苗穩定劑以及製藥業的其他重要用途。

約 90% 的藥用明膠用於製造常用的處方劑型，如軟膠囊、硬膠囊和片劑。

製藥業高度依賴明膠來提高藥物的穩定性、功效和生物有效性。藥用明膠有助於包覆和保護活性藥物成分，並在膜衣錠和發泡的研發中發揮關鍵作用。

明膠的生產涉及膠原蛋白的水解，該過程經過嚴格控制，以確保最終產品符合嚴格的藥品級標準。

全球藥用明膠市場動態

影響全球藥用明膠市場的關鍵市場動態是：

關鍵市場促進因素

生物醫學和化妝品：明膠擴大用於生物醫學和化妝品應用，包括創傷治療、傷口敷料、組織工程、基因治療、骨骼替代品、植入等。明膠的多種特性使其成為一種有價值的成分，在這些領域提供必不可少的功能，例如組織再生和藥物輸送。

藥用級明膠需求不斷成長：藥用級明膠需求的不斷成長也是市場的主要驅動力。需求的成長歸因於糖尿病、癌症和心血管疾病等慢性疾病的日益流行，這些疾病需要持續用藥和複雜的藥物配方。藥用明膠在這些製劑中至關重要，尤其是緩釋性膠囊和軟膠囊，它們比傳統藥片具有更高的生物利用度，也更容易吞嚥。由於軟膠囊的消費者友善特性，人們開始轉向軟膠囊，這進一步推動了藥用明膠的需求。

再生醫學：明膠製造技術的進步使生產過程更有效率、更具成本效益，從而支持了市場的成長。隨著再生醫學和組織工程領域的不斷發展，明膠在治療應用方面的需求也越來越大，這也成為成長的催化劑。明膠在這些領域的關鍵作用凸顯了其在製藥業的重要性。

魚明膠在免疫學中的應用：魚明膠的應用也越來越受歡迎，因為它比傳統來源的明膠有許多優點。魚明膠具有免疫安全性，可降低傳播牛腦病變和口蹄疫等疾病的風險，並具有環境和經濟效益。這些因素促使人們對魚明膠的偏好日益成長，並提升了其在醫藥領域的市場佔有率。

強化軟糖的流行：強化軟糖作為維生素和礦物質的替代輸送系統，其需求激增也推動了藥用明膠市場的成長。明膠的天然來源、生物相容性、熱可逆性和潔淨標示適用性等特性使其成為這些應用的理想選擇。

主要挑戰

替代成分的存在：對羥丙基甲基纖維素 (HPMC) 和改性澱粉等植物來源替代品的需求日益成長，正在對製藥業產生影響。這些替代成分擴大被用於生產素食和純素膠囊殼。素食和植物來源產品的日益成長趨勢給動物基明膠市場帶來了挑戰，並可能導致其需求下降。

對動物性明膠的擔憂：藥用明膠主要來自動物產品，例如牛和豬皮及骨。圍繞著動物性成分使用的文化、宗教和倫理擔憂，已導致消費者和監管機構的審查力度加大。這些擔憂促使人們尋找明膠的替代來源和替代品，這可能會限制市場成長。

替代品的可用性：替代輔料和藥物成分（包括植物來源或合成聚合物）的出現，對藥用明膠市場構成了挑戰。製造商可能會選擇這些替代品來滿足消費者對素食或純素產品的偏好，或解決對動物性成分的擔憂。這些變化可能會影響傳統藥用明膠的需求。

原料價格波動：明膠生產中使用的原料（例如獸皮、骨骼和毛皮）價格波動劇烈。受供需動態、影響牲畜的環境因素以及地緣政治問題的影響，這些價格波動可能會影響生產成本和利潤率。此類價格波動可能給藥明膠市場帶來挑戰。

過敏原問題：明膠過敏雖然罕見，但敏感族群也可能出現明膠過敏，導致對含明膠藥物產生不良反應。此類過敏原問題可能會影響消費者的選擇，尤其是已知過敏或尋求替代劑型的消費者。此類問題可能會限制某些患者族群對明膠藥物的接受度。

主要趨勢

新興市場擴張：亞太、中東、拉丁美洲和非洲等新興地區為藥用明膠市場帶來了巨大的機會。為了滿足日益成長的藥用明膠需求，各公司越來越關注這些地區。例如，領先的製造商正在印度和中國等國家擴大業務和產能。這一趨勢的驅動力在於這些經濟體對明膠日益成長的需求、原料供應充足以及低廉的人事費用，這些因素共同為市場帶來了巨大的成長前景。

創新應用與技術：技術進步正在推動明膠在製藥業的創新應用蓬勃發展。 etectRx, Inc. 開發的 ID-Cap 系統就是一個顯著的例子，該系統將硬明膠膠囊與可吞嚥的無線感測器和穿戴式讀取器整合在一起，用於監測服藥依從性。此類技術創新正在擴大明膠在智慧膠囊等先進應用中的使用，而智慧膠囊預計將透過增強明膠基產品的功能性和吸引力來推動市場成長。

聚焦明膠表徵：分析技術的進步正在改進明膠表徵方法，提高產品品質和一致性。這些進步使我們能夠更精確地控制明膠的物理和化學特性，確保其符合嚴格的製藥應用要求。改進的表徵方法有助於開發高品質的明膠產品，這對於有效的藥物傳輸和製劑至關重要。

改性明膠的開發：研究人員正在積極開發具有特定性能的改性明膠，用於標靶藥物遞送和其他特殊藥物應用。這些改質明膠旨在滿足特定的性能標準，例如控制釋放或提高穩定性，從而顯著提高藥物製劑的有效性，並拓展明膠在製藥業的應用範圍。

探索植物來源替代品：雖然動物基明膠仍佔據市場主導地位，但人們對植物來源替代品的興趣日益濃厚。此類替代品的開發是為了滿足飲食偏好和宗教限制，這些限制不允許使用動物產品。消費者對純素食和素食產品的需求日益成長，推動了植物來源膠替代品的探索，旨在提供符合倫理和文化考慮的解決方案。

Pharmaceutical gelatin, derived fr.om the partial hydrolysis of collagen obtained from animal skin, white connective tissues, and bones, is characterized by its high molecular weight, thermo-reversibility, biocompatibility, and water solubility. These properties make it a crucial excipient in the pharmaceutical industry.

Gelatin is predominantly used in the manufacture of hard capsules and soft gels, serving as a protective barrier that shields sensitive ingredients, such as fish oil, from oxygen, light, contamination, and microbiological growth.

Its applications extend to binding agents in tablet formulations, stabilizers in vaccines, and other vital uses in pharmaceutical products.

Approximately 90% of gelatin produced for pharmaceutical purposes is utilized in creating commonly prescribed dose forms, including softgels, hard capsules, and tablets.

The pharmaceutical industry relies heavily on gelatin due to its ability to enhance drug stability, effectiveness, and bioavailability. Pharmaceutical gelatin helps encapsulate and protect active pharmaceutical ingredients and plays a critical role in developing film-coated and effervescent tablets.

The production of gelatin involves the hydrolysis of collagen, which is carefully controlled to ensure the final product meets stringent pharma-medical grade standards.

Global Pharmaceutical Gelatin Market Dynamics

The key market dynamics that are shaping the global pharmaceutical gelatin market include:

Key Market Drivers

Biomedical and Cosmetic: The growing use of gelatin in biomedical and cosmetic applications, including wound healing, wound dressing, tissue engineering, gene therapy, bone substitutes, and implants. Gelatin's versatile properties make it a valuable component in these areas, providing essential functions such as tissue regeneration and drug delivery.

Increasing Demand for Pharmaceutical Grade: The rising demand for pharmaceutical-grade gelatin is also a significant market driver. This increase is attributed to the escalating prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, which require ongoing medication and sophisticated drug formulations. Pharmaceutical gelatin is crucial in these formulations, particularly in sustained-release and soft gel capsules, which offer better bioavailability and are easier to swallow compared to traditional tablets. The shift towards soft gel capsules, driven by their consumer-friendly characteristics, is further fueling the demand for pharmaceutical gelatin.

Regenerative Medicine: The advancements in gelatin manufacturing technologies are enhancing the efficiency and cost-effectiveness of production processes, thereby supporting market growth. The increasing application of gelatin in regenerative medicine and tissue engineering is another growth catalyst, as these fields expand and demand more advanced materials for therapeutic applications. Gelatin's role as a key component in these areas highlights its importance in the pharmaceutical industry.

Fish Gelatin in Immunological: The use of fish-derived gelatin is also gaining traction, offering several advantages over traditional sources. Fish gelatin is immunologically safe, reduces the risk of transmitting diseases such as bovine spongiform encephalopathy and foot-and-mouth disease, and provides environmental and economic benefits. These factors contribute to the growing preference for fish gelatin, driving its market share within the pharmaceutical sector.

Popularity for Fortified Gummies: The surge in demand for fortified gummies, which serve as alternative delivery systems for vitamins and minerals, is also contributing to the growth of the pharmaceutical gelatin market. Gelatin's properties, such as its natural origin, biocompatibility, thermo-reversibility, and clean label-friendly characteristics, make it an ideal choice for these applications.

Key Challenges:

Presence of Substitute Components: The rising demand for plant-based alternatives, such as hydroxypropyl methylcellulose (HPMC) and modified starch, is influencing the pharmaceutical industry. These substitutes are increasingly used to produce vegetarian and vegan capsule shells. As the trend toward veganism and plant-based products grows, it poses a challenge to the market for animal-derived gelatin, potentially reducing its demand.

Concerns Regarding Animal-Derived Gelatin: Pharmaceutical gelatin is primarily sourced from animal by-products, such as bovine or porcine skin and bones. Cultural, religious, and ethical concerns surrounding the use of animal-derived ingredients are leading to increased scrutiny from consumers and regulatory bodies. These concerns are driving the search for alternative sources and substitutes for gelatin, which could limit market growth.

Availability of Alternatives: The availability of alternative excipients and formulation ingredients, including plant-based or synthetic polymers, presents a challenge to the pharmaceutical gelatin market. Manufacturers may opt for these alternatives to meet consumer preferences for vegetarian or vegan products or to address concerns related to animal-derived ingredients. This shift could impact the demand for traditional pharmaceutical gelatin.

Price Volatility of Raw Materials: The cost of raw materials used in gelatin production, such as animal hides, bones, and skins, can be volatile. Fluctuations in these prices, driven by supply and demand dynamics, environmental factors affecting livestock, and geopolitical issues, can affect production costs and profit margins. This price instability may pose a challenge to the pharmaceutical gelatin market.

Allergen Concerns: Although rare, gelatin allergies can occur in sensitive individuals, leading to adverse reactions from gelatin-containing pharmaceutical products. These allergen concerns can influence consumer choices, particularly among those with known allergies or those seeking alternative dosage forms. Such concerns could limit the adoption of pharmaceutical gelatin in certain patient populations.

Key Trends

Expansion in Emerging Markets: Emerging regions such as Asia-Pacific, the Middle East, Latin America, and Africa present substantial opportunities for the pharmaceutical gelatin market. Companies are increasingly focusing on these areas to tap into the growing demand for pharmaceutical-grade gelatin. For instance, major manufacturers are expanding their presence and production capabilities in countries like India and China. This trend is driven by the rising demand for gelatin in these economies, the availability of raw materials, and lower labor costs, which collectively provide significant growth prospects for the market.

Innovative Applications and Technologies: The pharmaceutical industry is witnessing a surge in innovative applications of gelatin, driven by advancements in technology. A notable example is etectRx, Inc.'s development of the ID-Cap System. This system integrates a hard gelatin capsule with an embedded ingestible wireless sensor and a wearable reader to monitor drug adherence. Such innovations are expanding the use of gelatin in advanced applications, such as smart capsules, and are likely to drive market growth by enhancing the functionality and appeal of gelatin-based products.

Focus on Gelatin Characterization: Advances in analytical techniques are improving the characterization of gelatin, leading to enhanced product quality and consistency. These advancements enable more precise control over gelatin's physical and chemical properties, ensuring that it meets the stringent requirements of pharmaceutical applications. Improved characterization supports the development of high-quality gelatin products that are critical for effective drug delivery and formulation.

Development of Modified Gelatins: Researchers are actively developing modified gelatins with specific properties tailored for targeted drug delivery and other specialized pharmaceutical applications. These modified gelatins are designed to meet specific performance criteria, such as controlled release or enhanced stability, which can significantly improve the efficacy of drug formulations and expand the range of applications for gelatin in the pharmaceutical industry.

Exploration of Plant-Based Alternatives: Although animal-derived gelatin remains dominant in the market, there is growing interest in plant-based alternatives. These alternatives are being developed to cater to dietary preferences and religious restrictions that preclude the use of animal-based products. The exploration of plant-based gelatin substitutes is driven by increasing consumer demand for vegan and vegetarian products and aims to provide solutions that align with ethical and cultural considerations.

Global Pharmaceutical Gelatin Market Regional Analysis

Here is a more detailed regional analysis of the global pharmaceutical gelatin market:

North America

North America substantially dominates the global pharmaceutical gelatin market and is expected to maintain its dominance throughout the forecast period driven by a combination of well-established pharmaceutical industries, robust research and development (R&D) activities, and a growing demand for pharmaceutical products.

As the largest market for pharmaceutical gelatin in North America, the United States benefits from a mature pharmaceutical industry and significant investments in R&D. The country's market growth is supported by the presence of leading gelatin manufacturers, increasing demand for nutraceuticals, and substantial funding for innovation in drug delivery systems.

The U.S. pharmaceutical sector's advanced infrastructure and high standards for product quality further drive the demand for pharmaceutical-grade gelatin, contributing to its dominance in the market.

Canada also holds a significant share of the North American pharmaceutical gelatin market. The growth in Canada is driven by an aging population, a rising prevalence of chronic diseases, and a growing need for advanced drug delivery solutions.

North America's stringent regulatory framework and high-quality standards have created a strong demand for pharmaceutical gelatin products. The region's focus on maintaining rigorous quality control and ensuring compliance with health regulations enhances the credibility and safety of pharmaceutical products.

The North American region's commitment to improving healthcare infrastructure and investing in pharmaceutical research supports the expansion of the pharmaceutical gelatin market.

Asia Pacific

The Asia-Pacific region is poised fastest growth in the global pharmaceutical gelatin market, driven by a convergence of factors that are creating a favorable environment for expansion.

The region's burgeoning pharmaceutical industry is a key driver, with both domestic and multinational companies making significant investments in research and development, manufacturing, and distribution. This growth is complemented by the easy availability of gelatin sources, which supports the increasing demand for this critical excipient.

The region's rising population and increasing life expectancy. The growing and aging demographic is leading to a higher demand for healthcare services and medications, which in turn fuels the need for pharmaceutical gelatin.

The region's robust pharmaceutical sector is fostering a dynamic market environment, where the demand for high-quality gelatin is rising in tandem with the industry's expansion.

Additionally, the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer is contributing to the growing need for pharmaceutical products. Gelatin plays a crucial role in the formulation of various medications and supplements that address these chronic health issues.

As more individuals move into higher income brackets, there is a corresponding rise in healthcare expenditure, including spending on advanced pharmaceutical products that often incorporate gelatin.

Furthermore, favorable government initiatives are playing a significant role in supporting the pharmaceutical industry across the region. Many countries are implementing policies designed to boost the pharmaceutical sector, creating an advantageous environment for gelatin manufacturers.

Global Pharmaceutical Gelatin Market: Segmentation Analysis

The Global Pharmaceutical Gelatin Market is segmented based on Type, Application, Source, End-Use, And Geography.

Pharmaceutical Gelatin Market, By Type

Type A Gelatin

Type B Gelatin

Based on Type, the Global Pharmaceutical Gelatin Market is bifurcated into Type A Gelatin and Type B Gelatin. The Type B Gelatin segment dominates the global pharmaceutical gelatin market owing to the cost-effective production associated with the availability of raw materials, which helps to keep manufacturing costs down. Type B gelatin, in particular, offers increased gel storage stability compared to low-bloom gelatin, making it a preferred choice among industry players. This enhanced stability ensures that the soft gels maintain their quality and effectiveness over time, further bolstering the segment's growth and prominence in the market.

Pharmaceutical Gelatin Market, By Application

Hard Capsules

Softgel Capsules

Coatings

Parenteral Formulations

Based on Application, the Global Pharmaceutical Gelatin Market is bifurcated into Hard Capsules, and Softgel Capsules. The Soft Gel Capsules segment leads the Global Pharmaceutical Gelatin Market. Soft gel capsules are ideal for low-dose, lipid-soluble medications, offering uniform content distribution that enhances effectiveness and reliability. Their superior bioavailability improves the absorption of active ingredients, making them a preferred choice for various pharmaceutical applications.

Pharmaceutical Gelatin Market, By Source

Bovine Gelatin

Porcine Gelatin

Chicken Gelatin

Marine Gelatin

Based on the Source, the Global Pharmaceutical Gelatin Market is bifurcated into Bovine Gelatin, Porcine Gelatin, Chicken Gelatin, and Marine Gelatin. Porcine gelatin dominates the global pharmaceutical gelatin market. Its quick manufacturing cycle and cost-effective production processes contribute to its widespread use in the industry. Additionally, porcine-based gelatin is utilized in a variety of pharmaceutical applications, including as a stabilizer in vaccines and capsules. According to the National Health Service (NHS), porcine-derived gelatin plays a crucial role in maintaining the efficacy and safety of these products, especially during and after storage. These benefits drive the strong market share of porcine-sourced gelatin, making it a preferred choice for pharmaceutical formulations.

Pharmaceutical Gelatin Market, By End-User

Protein Bars and Powder

Food & Beverage

Confectionery

Dairy Products

Based on the End-User, the Global Pharmaceutical Gelatin Market is bifurcated into Protein Bars and Powder, Food & Beverage, Confectionery, and Dairy Products. The food and beverage segment currently leads the pharmaceutical gelatin market, thanks to its extensive applications and well-established consumer base. Gelatin's versatility in various food products, including confectioneries, dairy items, and desserts, solidifies its dominant position in this sector.

Pharmaceutical Gelatin Market, By Geography

North America

Europe

Asia Pacific

Rest of the world

Based on Geography, the Global Pharmaceutical Gelatin Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America substantially dominates the global pharmaceutical gelatin market and is expected to maintain its dominance throughout the forecast period driven by a combination of well-established pharmaceutical industries, robust research and development (R&D) activities, and a growing demand for pharmaceutical products. As the largest market for pharmaceutical gelatin in North America, the United States benefits from a mature pharmaceutical industry and significant investments in R&D.

Key Players

The "Global Pharmaceutical Gelatin Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Nitta Gelatin, PB Leiner GmbH, Tessenderlo Group, Weishardt Holding GmbH & Co. KG, Gelita AG, LAPI Gelatine, S.p.A., NiOx Gelatin, Croda International Plc, Eastman Chemical Company, Rousselot (ADM), I gelatine SA, Gelnex Pharmaceuticals, Bio-Gelatin GmbH, Gelatin Kelco Co.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Pharmaceutical Gelatin Market Key Developments

In 2022, in response to the food industry's need to meet European Union food standards, Lonza enhanced their Capsugel contribution with a white hard gelatin capsule that is titanium dioxide-free.
In May 2021, Darling Ingredients Inc. announced the launch of X-Pure GelDAT Gelatin Desaminotyrosine for biomedical applications under the Rousselot brand, expanding its pure pharmaceutical-grade modified gelatin portfolio.
In July 2022, Gelita established a biotech hub to develop proteins for pharmaceutical and medical applications, cosmetics, and nutrition.
In May 2022, Capsugel expanded its titanium dioxide-free capsule line, adding white firm gelatin capsules that are free of titanium dioxide (TiO2). The novel titanium dioxide-free capsule is based on crystalline salts and delivers similar masking and whitening properties as titanium dioxide capsules. The product provides excellent light shielding and opacity.